Brief help for kids who resist bedtime
Official title: Brief Sleep Intervention for Bedtime Resistance
Run by Oregon Health and Science University · NCT06970392 · Data updated 2026-11-12
This project tests whether a short, primary-care delivered sleep visit using sleep hygiene education and a 'Bedtime Pass' can help 3- to 7-year-olds who have trouble falling asleep on their own.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Status | Recruiting |
| Started | May 29, 2025 |
| Main results expected | July 2026 |
| Study ends | September 2026 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT06970392 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Caregivers of English-speaking children aged 3–7 who receive primary care at the study locations and report bedtime resistance are the intended participants.
✕Probably not a fit
Children already receiving more intensive sleep treatment or those with severe intellectual disability or other conditions that prevent participation are unlikely to benefit from this brief intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a non-controlled feasibility trial delivering a brief behavioral sleep intervention during routine primary care visits by a behavioral health consultant. The intervention includes parent education on sleep hygiene and a 'Bedtime Pass' tool intended to reduce bedtime resistance. The study will measure whether the intervention can be delivered with fidelity within the time allotted and whether parents find it feasible and acceptable. No comparison group is included, as the focus is on implementation and acceptability in the primary care setting.
Why it matters
Potential benefit: If successful, families could gain a quick, clinic-based strategy to reduce bedtime struggles and help children fall asleep independently.
How similar studies have gone: Behavioral approaches such as sleep hygiene education and bedtime pass strategies have shown benefit in pediatric sleep research, but delivering them briefly within routine primary care is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Caregiver of a child aged 3-7 years who receives primary care services who endorses their child demonstrating bedtime resistance; English-speaking; receiving primary care at the study locations. Exclusion Criteria: * Existing receipt of more intensive sleep intervention; severe intellectual disability or other condition precluding participation.
Where it's running
-
Oregon Health & Science University
Portland, Oregon, United States Recruiting
Study contacts
- Principal investigator: Andrew R Riley — Oregon Health and Science University
- Study coordinator: Andrew R Riley, PhD
- Email: rileyand@ohsu.edu
- Phone: 503-494-1724
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Topical ruxolitinib for adults with pyoderma gangrenosum
This pilot study tests a topical cream of ruxolitinib to see if it helps heal PG ulcers in adults without adding systemic immunosuppressants.
-
Bright light therapy to help sleep after brain injury
This trial tests whether morning bright light therapy can improve sleep and related brain health markers in adults with a traumatic brain injury.
-
Transitioning from mavacamten to aficamten in obstructive HCM
This study tests whether switching from mavacamten to aficamten is feasible and safe for people with obstructive hypertrophic cardiomyopathy who are already on mavacamten.
-
Motor Activation Therapy after concussion: a targeted rehabilitation approach
This study tests a motor-activation focused physical therapy for people with persistent balance problems after a concussion to see if it improves their responses to imbalance.
-
L-fucose supplementation for adults with GLUT1 deficiency
This trial will test whether taking L-fucose supplements helps reduce ataxia and other symptoms in adults with GLUT1 deficiency.
-
Cefotetan Therapy for E. coli Infections
This pilot study tests whether cefotetan works for bloodstream infections caused by E. coli, compared with standard antibiotics, to see if it improves outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.